Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Connelly

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Annals of Diagnostic Pathology|December 13, 2002
E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinomaAmer Wahed, John Connelly, Tommy Reese
Dementia (London, England)|December 17, 2013
Dementia research--what do different public groups want? A survey by the Scottish Dementia Clinical Research NetworkEmma Law, John M Starr, Peter John Connelly
FEBS Letters|July 28, 2016
Sequence-specific DNA binding by AT-hook motifs in MeCP2Matthew J Lyst, John Connelly, Cara Merusi, et al.
Pharmacoeconomics|July 23, 2013
Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspectiveAnthony Bentley, Samantha Gillard, Michael Spino, et al.
Life Science Alliance|September 19, 2022
A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2Kashyap Chhatbar, John Connelly, Shaun Webb, et al.
Biomacromolecules|January 18, 2018
Highly Stable RNA Capture by Dense Cationic Polymer Brushes for the Design of Cytocompatible, Serum-Stable SiRNA Delivery VectorsDanyang Li, Amir S Sharili, John Connelly, et al.
Nature Reviews. Drug Discovery|July 18, 2002
Metabonomics: a platform for studying drug toxicity and gene functionJeremy K Nicholson, John Connelly, John C Lindon, et al.
Molecular Pharmacology|February 28, 2003
Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoleAnne Monks, Erik Harris, Curtis Hose, et al.
Therapeutic Innovation & Regulatory Science|August 20, 2025
A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a 'Study-A-Thon'Helen P Booth, John Connelly, Daniel Dedman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2008
Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variantsMarie-Odile Benoit-Biancamano, John Connelly, Lyne Villeneuve, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Annals of Diagnostic Pathology|December 13, 2002
E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinomaAmer Wahed, John Connelly, Tommy Reese
Dementia (London, England)|December 17, 2013
Dementia research--what do different public groups want? A survey by the Scottish Dementia Clinical Research NetworkEmma Law, John M Starr, Peter John Connelly
FEBS Letters|July 28, 2016
Sequence-specific DNA binding by AT-hook motifs in MeCP2Matthew J Lyst, John Connelly, Cara Merusi, et al.
Pharmacoeconomics|July 23, 2013
Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspectiveAnthony Bentley, Samantha Gillard, Michael Spino, et al.
Life Science Alliance|September 19, 2022
A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2Kashyap Chhatbar, John Connelly, Shaun Webb, et al.
Biomacromolecules|January 18, 2018
Highly Stable RNA Capture by Dense Cationic Polymer Brushes for the Design of Cytocompatible, Serum-Stable SiRNA Delivery VectorsDanyang Li, Amir S Sharili, John Connelly, et al.
Nature Reviews. Drug Discovery|July 18, 2002
Metabonomics: a platform for studying drug toxicity and gene functionJeremy K Nicholson, John Connelly, John C Lindon, et al.
Molecular Pharmacology|February 28, 2003
Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoleAnne Monks, Erik Harris, Curtis Hose, et al.
Therapeutic Innovation & Regulatory Science|August 20, 2025
A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a 'Study-A-Thon'Helen P Booth, John Connelly, Daniel Dedman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2008
Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variantsMarie-Odile Benoit-Biancamano, John Connelly, Lyne Villeneuve, et al.
Pageof 5